Wolverine Trading »

Nektar Therapeutics shares owned by Wolverine Trading

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Wolverine Trading from 13F filings

Historical chart of Wolverine Trading investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Wolverine Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Wolverine Trading

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 179k 58.92
2025-06-30 $2.8M 111k 25.76

More positions owned by Wolverine Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Apple (AAPL)
Strategy Cl A New (MSTR)
Spdr Gold Tr Gold Shs (GLD)
Netflix (NFLX)
Amazon (AMZN)
Broadcom (AVGO)
Palantir Technologies Cl A (PLTR)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Wolverine Trading

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics